Mark N Lampert's Net Worth

$2.82 Billion

Who is Mark N Lampert?

Mark N Lampert has an estimated net worth of $2.82 Billion. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, Cascadian Therapeutics, Inc., CATALYST BIOSCIENCES, INC., Allakos Inc., Rain Oncology Inc., ARENA PHARMACEUTICALS INC, IMMUNE DESIGN CORP., Capstone Therapeutics Corp., ChemoCentryx, Inc., DYNAVAX TECHNOLOGIES CORP, REPLIGEN CORP, KENT INTERNATIONAL HOLDINGS INC, NEUROCRINE BIOSCIENCES INC, XOMA Corp, LIGAND PHARMACEUTICALS INC, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PIERIS PHARMACEUTICALS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., PALATIN TECHNOLOGIES INC, MEDICINOVA INC, CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., ICAGEN INC, ADOLOR CORP, Third Harmonic Bio, Inc., Regado Biosciences Inc, FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARRAY BIOPHARMA INC, ARQULE INC, enGene Holdings Inc., Celera CORP, FACET BIOTECH CORP, AVIGEN INC \DE, POINT Biopharma Global Inc., SUPERGEN INC, COMBINATORX, INC, and NEUROBIOLOGICAL TECHNOLOGIES INC /CA/.

SEC CIK

Mark N Lampert's CIK is 0001233840

Past Insider Trading and Trends

2011 was Mark N Lampert's most active year for acquiring shares with 122 total transactions. Mark N Lampert's most active month to acquire stocks was the month of April. 2009 was Mark N Lampert's most active year for disposing of shares, totalling 74 transactions. Mark N Lampert's most active month to dispose stocks was the month of January. 2021 saw Mark N Lampert paying a total of $132,144,944.64 for 12,405,370 shares, this is the most they've acquired in one year. In 2020 Mark N Lampert cashed out on 18,981,731.772 shares for a total of $187,629,819.78, their largest year based on trade value.